Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Bravo! A Mosquito Antiviral Protein that Restricts Arboviruses through an RRM3-Dependent Nuclear Mechanism

Created on 18 Jul 2026

Authors

Walsh, E., St Clair, L. A., Ruckert, C.

Abstract

Culex quinquefasciatus mosquitoes are vectors for several medically important viruses, yet their antiviral immune responses remain understudied compared to Aedes mosquitoes. The aedine broadly antiviral protein (aBravo) is an RNA-binding protein that was found to inhibit arbovirus replication in Aedes aegypti, but the function of the Cx. quinquefasciatus Bravo ortholog (CqBravo) remains unknown. Here, we examined the role of CqBravo in antiviral immunity in Cx. quinquefasciatus-derived Hsu cells and mosquitoes. We found that CqBravo is also broadly antiviral in Cx. quinquefasciatus, reducing replication of La Crosse virus (LACV) and Usutu virus (USUV) in Hsu cells and Sindbis virus (SINV) in vivo. CqBravo localized to the nucleus, and truncation and mutational analyses identified an RNA recognition motif (RRM3) critical for nuclear localization and antiviral activity. Quantitative proteomic analysis revealed that full-length CqBravo expression was associated with distinct changes in host protein abundance that were lost following removal of RRM3. Proteins altered by CqBravo expression were enriched for pathways involved in genome maintenance, including DNA repair, DNA metabolism, and ATP-dependent DNA processing. Overall, we demonstrate that CqBravo is an important antiviral factor in Cx. quinquefasciatus mosquitoes and may play a broader role in mosquito antiviral immunity across species.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 18 Jul 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement